PKI (which I consider a biotech company) has quietly risen 60% in the past three months. It’s still cheap, IMO, and it has more than a modicum of buyout vig.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”